Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Viking Thera
(NQ:
VKTX
)
78.21
+1.24 (+1.61%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Viking Thera
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
2 Stocks That Have More Than Tripled This Year: Are They Buys?
March 15, 2024
Don't jump on the bandwaggon too quickly.
Via
The Motley Fool
Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market?
March 15, 2024
Viking Therapeutics just might be an attractive acquisition target for Pfizer.
Via
The Motley Fool
Check Out What Whales Are Doing With VKTX
March 14, 2024
Via
Benzinga
7 Biotech Stocks to Buy as Sector Rotation Ramps Up
March 13, 2024
With digital innovation possibly getting overextended, now’s the time to consider biotech stocks for an incoming rotation.
Via
InvestorPlace
Peering Into Viking Therapeutics's Recent Short Interest
March 13, 2024
Via
Benzinga
Unleashing the Bulls: 3 Top Stocks to Charge Ahead in March
March 13, 2024
This environment presents a compelling opportunity for investors seeking growth. Discover 3 top stocks primed for long-term growth in 2024.
Via
InvestorPlace
If You Invested $100 In This Stock 5 Years Ago, You Would Have $900 Today
March 11, 2024
Via
Benzinga
Is Viking Therapeutics Stock a Buy?
March 11, 2024
Its potential is looking increasingly more likely to be realized.
Via
The Motley Fool
Could Viking Therapeutics Challenge Giant Eli Lilly in the Billion-Dollar Weight-Loss Drug Market?
March 13, 2024
Viking aims to enter a market that may be worth $100 billion in a few years.
Via
The Motley Fool
1 Big New Reason to Buy Novo Nordisk Stock Hand Over Fist Right This Instant
March 12, 2024
The pharma giant could have yet another knockout obesity drug on the way.
Via
The Motley Fool
What's Going On With Viking Therapeutics (VKTX) Stock?
March 11, 2024
Viking Therapeutics shares are trading lower by 10.9% Monday afternoon. The stock has experienced marked volatility following a number of key company announcements in February.
Via
Benzinga
Missed Out on Eli Lilly and Novo Nordisk? This Could Be the Next Big Weight Loss Stock.
March 09, 2024
Viking Therapeutics has a promising anti-obesity treatment that is generating a lot of interest.
Via
The Motley Fool
3 Stock Winners That Are Up 1,000% or More in 2024
March 08, 2024
Dig deep enough, and find a story hot enough, and you can uncover potential stock winners up 1,000%. Here are three.
Via
InvestorPlace
9 Health Care Stocks Whale Activity In Today's Session
March 08, 2024
Via
Benzinga
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 07, 2024
Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 07, 2024
Via
Benzinga
Why Viking Therapeutics Stock Is Plunging Today
March 07, 2024
The sell-off could present a buying opportunity for aggressive investors willing to bet that the obesity market will be big enough for multiple winners.
Via
The Motley Fool
Novo Nordisk Jumps On Strong Results For New Weight-Loss Drug
March 07, 2024
Amycretin showed a 13.1% weight loss after 12 weeks in a phase 1 trial.
Via
Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
March 06, 2024
Via
Benzinga
Vivani Medical Surges on its Ozempic-Like Weight-Loss Implant
March 06, 2024
The Ozempic craze continues to make headlines in the medical sector, and GLP-1 drug stocks such as Vivani Medical continue to surge higher
Via
MarketBeat
Exposures
Product Safety
Is Viking Therapeutics Stock a Better Buy Than Eli Lilly and Novo Nordisk After the Latest Weight-Loss Drug News?
March 06, 2024
A new player in the multibillion-dollar weight-loss drug market could be waiting in the wings.
Via
The Motley Fool
A New Competitor to Wegovy Could Be on the Way. Should Novo Nordisk Be Worried?
March 05, 2024
Here's why I'm not worried.
Via
The Motley Fool
Better Weight Loss Drug Stock: Viking Therapeutics vs. Eli Lilly
March 05, 2024
One is a reigning champion, and the other is a burgeoning contender.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
March 04, 2024
Via
Benzinga
1 Wall Street Analyst Thinks Viking Therapeutics Stock Is Going to $116. Is It a Buy Around $81?
March 04, 2024
It could have even further to rise after its massive run-up.
Via
The Motley Fool
Beyond the "Mag 7": 3 Risk-On Market Forces
March 03, 2024
The biggest bear argument over the past year has been slim leadership in the market, namely concentrated in mega-cap tech stocks such as the “Mag 7.” However, dig deeper, and you will discover there's...
Via
Talk Markets
Better Buy: Eli Lilly vs. Viking Therapeutics
March 03, 2024
These two biotechs could eventually go head to head in a fast-growing market.
Via
The Motley Fool
Missed Out on Novo Nordisk Stock? Buy This 1 Biotech Stock Right Now.
March 03, 2024
The battle for the obesity therapies market is escalating.
Via
The Motley Fool
Why Novo Nordisk Stock Topped the Market Today
March 01, 2024
A favorite of both investors and analysts gets a boost from a bullish move by a pundit.
Via
The Motley Fool
Stock Market Rally At Highs After Big Earnings, Inflation Data: Weekly Review
March 01, 2024
The Nasdaq is on the cusp of setting a record high.
Via
Investor's Business Daily
Topics
Economy
Exposures
Interest Rates
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.